Efficacy of Advanced Radiotherapy (ART) in Prostate Cancer Patients With Early Stage, Advanced, Metastatic and Relapsed Disease (PROST-ART)

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Observational
SUMMARY

This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024. Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022 Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 95
View:

• Prostate cancer patients, \> 18 years old, treated with IGRT, IMRT, SBRT

Locations
Other Locations
Italy
IRCCS San Raffaele Scientific Institute
RECRUITING
Milan
Contact Information
Primary
Andrei Fodor, MD
fodor.andrei@hsr.it
+39-0226437634
Backup
Nadia G Di Muzio, Prof
dimuzio.nadia@hsr.it
+39-0226437643
Time Frame
Start Date: 2022-02-14
Estimated Completion Date: 2027-12-14
Participants
Target number of participants: 2500
Treatments
Prostate cancer, localized disease
Patients treated with IGRT, IMRT, SBRT, with radical intent for localized prostate cancer will be evaluated~Other Names:~Intensity Modulated Radiotherapy Stereotactic Body Radiotherapy
Prostate cancer, extensive disease
Patients operated on for prostate cancer, treated with IGRT, IMRT, SBRT in adjuvant setting will be evaluated~Other Names:~Intensity Modulated Radiotherapy Stereotactic Body Radiotherapy
Prostate cancer, biochemical relapse
Patients operated on for prostate cancer and treated with IGRT, IMRT, SBRT for biochemical relapse will be evaluated
Prostate cancer, oligometastatic disease ( lymph-nodal, bone, visceral)
Prostate cancer patients treated with IGRT, IMRT, SBRT, in radical setting or as salvage radiotherapy for relapse after previous treatments will be evaluated
Related Therapeutic Areas
Sponsors
Leads: IRCCS San Raffaele

This content was sourced from clinicaltrials.gov